Dr Harold J. Burstein of the Dana-Farber Cancer Institute, Boston, highlights key ER+ breast cancer abstracts from the 2025 San Antonio Breast Cancer Symposium. Beginning with the metastatic setting, ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
A single-drug approach for newly diagnosed multiple myeloma may simplify treatment while maintaining efficacy, improving patient quality of life. Suleika Jaouad's leukemia experience highlights the ...
Prescriptions for antiparasitic drugs spiked after the actor claimed it cured his friends of cancer, a new study finds.